XURAMPIC Trademark

Trademark Overview


On Wednesday, July 16, 2014, a trademark application was filed for XURAMPIC with the United States Patent and Trademark Office. The USPTO has given the XURAMPIC trademark a serial number of 86338545. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 13, 2022. This trademark is owned by AstraZeneca AB. The XURAMPIC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, inflammation, infection, gastrointestinal diseases and disorders, and nervous system diseases and disorders
xurampic

General Information


Serial Number86338545
Word MarkXURAMPIC
Filing DateWednesday, July 16, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 13, 2022
Registration Number4843839
Registration DateTuesday, November 3, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 17, 2015

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, inflammation, infection, gastrointestinal diseases and disorders, and nervous system diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 13, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE

Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE

Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE

Trademark Events


Event DateEvent Description
Friday, May 13, 2022CANCELLED SEC. 8 (6-YR)
Tuesday, November 3, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, February 8, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 3, 2015REGISTERED-PRINCIPAL REGISTER
Monday, September 28, 20151(B) BASIS DELETED; PROCEED TO REGISTRATION
Wednesday, September 16, 2015NOTICE OF ALLOWANCE CANCELLED
Monday, September 28, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 16, 2015TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, May 12, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 17, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 17, 2015PUBLISHED FOR OPPOSITION
Wednesday, February 25, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, February 6, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, February 5, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 5, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 5, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 29, 2015ASSIGNED TO LIE
Thursday, January 15, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 25, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 25, 2014NON-FINAL ACTION E-MAILED
Monday, August 25, 2014NON-FINAL ACTION WRITTEN
Tuesday, August 19, 2014ASSIGNED TO EXAMINER
Tuesday, July 22, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, July 19, 2014NEW APPLICATION ENTERED IN TRAM